visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Memo Therapeutics Ag

    Get Full Access

    Description

    • Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis. Its MemoMAB platform creates a recombinant in vitro copy of an individuals B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individuals immune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery. The business strategy of MEMO is the discovery of therapeutic antibody candidates and target discovery for antibody and vaccine development. MemoMAB is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
    • location

      Headquarters:Ielab Ethz Hpl D16.2 Otto-Stern-Weg 7, Zurich, , United States

      More
    • Memo Therapeutics Ag phone

      Phone Number:

    • Memo Therapeutics Ag website

      Website: memo-therapeutics.com

    • Memo Therapeutics Ag employees

      Employees:11

    • Memo Therapeutics Ag revenue

      Revenue:$10 - 50M

    • Memo Therapeutics Ag legal name

      Legal Name:Memo Therapeutics Ag

    • Memo Therapeutics Ag's Social Media

      Memo Therapeutics Ag linkedin
    • done Is this data correct?

    • |  NAICS Code: 541713  |

      Show More
    Person level website identification

    CEO for Memo Therapeutics Ag

    Karsten Fischer

    Chief Executive Officer

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    George Badita

    Chief Medical Officer

    Thomas Taapken

    Member Of The Board

    Lars Spenger

    Head Of Finance

    Matthieu Delincé

    Head Of Antibody Screening

    Simone Schmitt

    Director Antibody Development

    Frequently Asked Questions regarding Memo Therapeutics Ag

    • Where are Memo Therapeutics Ag's Headquarters?

      Memo Therapeutics Ag's Headquarters are in Ielab Ethz Hpl D16.2 Otto-Stern-Weg 7,Zurich,,United States

    • What is Memo Therapeutics Ag's official website?

      Memo Therapeutics Ag's official website is memo-therapeutics.com

    • What is Memo Therapeutics Ag's Revenue?

      Memo Therapeutics Ag's revenue is $10 - 50M

    • What is Memo Therapeutics Ag's NAICS code?

      Memo Therapeutics Ag's NAICS code is 541713

    • How many employees are working in Memo Therapeutics Ag

      Memo Therapeutics Ag has 11 employees

    • What is Memo Therapeutics Ag's Industry?

      Memo Therapeutics Ag is in the industry of Biotechnology

    • Who is Memo Therapeutics Ag's CEO?

      Memo Therapeutics Ag's CEO is Karsten Fischer

    • Who is Memo Therapeutics Ag's Chief Medical Officer?

      Memo Therapeutics Ag's Chief Medical Officer is George Badita

    Company Directory